Monthly Communication Report

Organization:	Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration:	782797-371-73
Communication date:	2019-06-20
Posted date:	2019-07-11

Designated Public Office Holders who participated in the communication:	Mathew Clancy -, Press Secretary, Shadow Cabinet House of Commons Party Officers, House of Commons Nik Zylstra, Policy Advisor House of Commons Party Officers, House of Commons
Subject Matter of the communication:	Health,  Industry,  Intellectual Property,  Science and Technology
Communication report replaced on:	2019-11-28 amended entry: 371-460934
Responsible Officer who filed this communication report:	Pamela Fralick
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.